电疗法,制造商的责任,和学习的中间人
1Department of Psychiatry, Columbia University, New York City.
Psychiatric services (Washington, D.C.)
|November 19, 2024
概括
学习中介规则保护药物和设备制造商免受患者直接警告. 加利福尼亚州的一家法院现在让患者更容易为未披露的风险寻求赔偿,比如电治疗导致的记忆丧失.
科学领域:
- 医疗法 法律 医疗法
- 产品责任 产品责任 产品责任
- 神经学 神经学
背景情况:
- 学习中介规则保护制药和医疗器械制造商免受直接患者披露要求.
- 制造商有义务向处方医生警告与其产品相关的潜在风险.
- 确定患者因未披露风险而造成的损害的赔偿存在法律挑战.
研究的目的:
- 分析加利福尼亚州最高法院在涉及电疗法 (ECT) 的案件中关于学术中介规则的裁决.
- 检查法院的决定如何影响患者因缺乏风险披露而造成伤害的赔偿能力.
主要方法:
- 法律案例分析专注于加利福尼亚州最高法院的决定.
- 检查法律标准,以证明缺乏警告和伤害患者之间的因果关系.
主要成果:
- 法院扩大了原告证明没有警告直接造成损害的标准.
- 这一扩展简化了患者寻求因未公开风险造成的损害赔偿的过程.
结论:
- 加利福尼亚州最高法院的裁决可能会加强患者对制造商的诉讼,因为制造商未能披露已知的风险.
- 这一决定可能会导致药物和设备制造商在风险沟通方面承担更多责任.
相关概念视频
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
253
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
253
Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284


